INSUBCONTINENT EXCLUSIVE:
Dr CK Narayan of Chart Advise has a sell call on Cadila Healthcare Ltd
with a target price of Rs 345
The current market price of Cadila Healthcare Ltd
Time period given by the analyst is Intra Day when Cadila Healthcare Ltd
price can reach the defined target
Dr CK Narayan recommended to keep stoploss at Rs 362
Cadila Healthcare Ltd., incorporated in 1995, is a largecap company with a market cap
of Rs 36296.79 crore.
Cadila Healthcare Ltd
key Products/Revenue Segments include Pharmaceutical Products which contributed Rs 3098.00 Crore to Sales Value (94.60 % of Total Sales),
Export Incentives which contributed Rs 85.00 Crore to Sales Value (2.59 % of Total Sales), Other Operating Revenue which contributed Rs
82.10 Crore to Sales Value (2.50 % of Total Sales) and Royalty Income which contributed Rs 9.40 Crore to Sales Value (0.28 % of Total
Sales)for the year ending 31-Mar-2017
For the quarter ended 30-06-2018, the company has reported a Consolidated sales of Rs 2768.70 Crore, down -12.18 % from last quarter Sales
of Rs 3152.70 Crore and up 29.64 % from last year same quarter Sales of Rs 2135.70 Crore Company has reported net profit after tax of Rs
449.20 Crore in latest quarter
Patel, Mr.Nitin R Desai, Mr.Pankaj R Patel, Ms.Dharmishta N Rawal
Company has Mukesh M Shah Co
as its auditoRs As on 30-06-2018, the company has a total of 1,023,742,600 shares outstanding
